GSK2033
≥98%
- Product Code: 62653
CAS:
1221277-90-2
| Molecular Weight: | 591.66 g./mol | Molecular Formula: | C₂₉H₂₈F₃NO₅S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
GSK2033 is primarily utilized in research settings as a selective inhibitor of the LXRβ (Liver X Receptor beta) nuclear receptor. It is widely used in studies aimed at understanding the role of LXRβ in metabolic processes, including cholesterol homeostasis, lipid metabolism, and inflammation. Researchers employ GSK2033 to investigate its potential therapeutic effects in diseases such as atherosclerosis, diabetes, and neurodegenerative disorders. Its specificity for LXRβ makes it a valuable tool for dissecting the distinct functions of LXR isoforms (LXRα and LXRβ) in cellular and animal models. Additionally, GSK2033 is used to explore its impact on gene regulation and signaling pathways associated with LXRβ activation, contributing to the development of targeted therapies for metabolic and inflammatory conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿8,361.00 |
+
-
|
| 0.010 | 10-20 days | ฿14,823.00 |
+
-
|
GSK2033
GSK2033 is primarily utilized in research settings as a selective inhibitor of the LXRβ (Liver X Receptor beta) nuclear receptor. It is widely used in studies aimed at understanding the role of LXRβ in metabolic processes, including cholesterol homeostasis, lipid metabolism, and inflammation. Researchers employ GSK2033 to investigate its potential therapeutic effects in diseases such as atherosclerosis, diabetes, and neurodegenerative disorders. Its specificity for LXRβ makes it a valuable tool for dissecting the distinct functions of LXR isoforms (LXRα and LXRβ) in cellular and animal models. Additionally, GSK2033 is used to explore its impact on gene regulation and signaling pathways associated with LXRβ activation, contributing to the development of targeted therapies for metabolic and inflammatory conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :